Skip to main content
Erschienen in: Journal of Neurology 2/2010

01.02.2010 | Original Communication

Taste in mild cognitive impairment and Alzheimer’s disease

verfasst von: Silke Steinbach, Walter Hundt, Andreas Vaitl, Petra Heinrich, Stefan Förster, Katharina Bürger, Thomas Zahnert

Erschienen in: Journal of Neurology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

In this prospective study we investigated the quantitative and qualitative taste function of patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). 29 healthy, elderly subjects, 29 MCI and 30 AD patients were tested using a validated taste test, the “taste strips”. Additionally, odor identification, odor discrimination, odor threshold, the mini-mental state examination (MMSE) and Apo E epsilon 4 status were examined. Regarding taste, there was a significant reduction of total taste scores and also the score for individual tastes on either side of the tongue between controls and MCI/AD patients. There was no significant difference in the taste scores between MCI and AD patients. A taste test may be a useful procedure for differentiating between healthy subjects and patients with MCI/AD in a clinical context. For diagnosing MCI versus AD, further tests such as smell test, MMSE, Apo E epsilon 4 status, FDG-PET and MRI appear to be useful.
Literatur
1.
Zurück zum Zitat Bacon AW, Bondi MW, Salmon DP, Murphy C (1998) Very early changes in olfactory functioning due to Alzheimer’s disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 855:723–731CrossRefPubMed Bacon AW, Bondi MW, Salmon DP, Murphy C (1998) Very early changes in olfactory functioning due to Alzheimer’s disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 855:723–731CrossRefPubMed
2.
Zurück zum Zitat Bickel H (2001) Demenzen im höheren Lebensalter: Schätzungen des Vorkommens und der Versorgungskosten. Z Gerontol Geriatr 34:108–115CrossRefPubMed Bickel H (2001) Demenzen im höheren Lebensalter: Schätzungen des Vorkommens und der Versorgungskosten. Z Gerontol Geriatr 34:108–115CrossRefPubMed
3.
Zurück zum Zitat Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, Rusinek H, Wisniewski HM (2000) The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer’s disease. Neuroscience 95:721–725CrossRefPubMed Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, Rusinek H, Wisniewski HM (2000) The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer’s disease. Neuroscience 95:721–725CrossRefPubMed
4.
Zurück zum Zitat Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92:197–201CrossRefPubMed Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92:197–201CrossRefPubMed
5.
Zurück zum Zitat Braak H, Braak E (1998) Evolution of neuronal changes in the course of Alzheimer’s disease. J Neural Transm Suppl 53:127–140PubMed Braak H, Braak E (1998) Evolution of neuronal changes in the course of Alzheimer’s disease. J Neural Transm Suppl 53:127–140PubMed
6.
Zurück zum Zitat Carlsson CM (2008) Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer’s disease: future directions. J Alzheimers Dis 15:327–338PubMed Carlsson CM (2008) Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer’s disease: future directions. J Alzheimers Dis 15:327–338PubMed
7.
Zurück zum Zitat Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA (2006) Alterations in memory networks in mild cognitive impairment and Alzheimer’s disease: an independent component analysis. J Neurosci 26:10222–10231CrossRefPubMed Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA (2006) Alterations in memory networks in mild cognitive impairment and Alzheimer’s disease: an independent component analysis. J Neurosci 26:10222–10231CrossRefPubMed
8.
Zurück zum Zitat Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC (2003) Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 60:1374–1377PubMed Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC (2003) Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 60:1374–1377PubMed
9.
Zurück zum Zitat Crum RM, Anthony JC, Bassett SS, Folstein MF (1993) Population-based norms for the mini-mental state examination by age and educational level. JAMA 269:2386–2391CrossRefPubMed Crum RM, Anthony JC, Bassett SS, Folstein MF (1993) Population-based norms for the mini-mental state examination by age and educational level. JAMA 269:2386–2391CrossRefPubMed
10.
Zurück zum Zitat De Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, Desanti S, McRae T, Ferris SH, Reisberg B, Ince C, Rusinek H, Bobinski M, Quinn B, Miller DC, Wisniewski HM (1997) Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease. Neurobiol Aging 18:1–11CrossRefPubMed De Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, Desanti S, McRae T, Ferris SH, Reisberg B, Ince C, Rusinek H, Bobinski M, Quinn B, Miller DC, Wisniewski HM (1997) Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease. Neurobiol Aging 18:1–11CrossRefPubMed
11.
Zurück zum Zitat Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology 52:1158–1165PubMed Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology 52:1158–1165PubMed
12.
Zurück zum Zitat Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R (2000) Olfactory deficit in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 157:1399–1405CrossRefPubMed Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R (2000) Olfactory deficit in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 157:1399–1405CrossRefPubMed
13.
Zurück zum Zitat Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 29:693–706CrossRefPubMed Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 29:693–706CrossRefPubMed
14.
Zurück zum Zitat Doty RL, Reyes PF, Gregor T (1987) Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Res Bull 18:597–600CrossRefPubMed Doty RL, Reyes PF, Gregor T (1987) Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Res Bull 18:597–600CrossRefPubMed
15.
Zurück zum Zitat Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, Amabile G, Fusetti M (2005) Olfactory screening test in mild cognitive impairment. Neurol Sci 26:156–160CrossRefPubMed Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, Amabile G, Fusetti M (2005) Olfactory screening test in mild cognitive impairment. Neurol Sci 26:156–160CrossRefPubMed
16.
Zurück zum Zitat Folstein MF, Folstein SE, McHigh PR (1975) Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHigh PR (1975) Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
17.
Zurück zum Zitat Friedland RP, Brun A, Budinger TF (1985) Pathological and positron emission tomographic correlations in Alzheimer’s disease. Lancet 26:228CrossRef Friedland RP, Brun A, Budinger TF (1985) Pathological and positron emission tomographic correlations in Alzheimer’s disease. Lancet 26:228CrossRef
18.
Zurück zum Zitat Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. Lancet 367:1262–1270CrossRefPubMed Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. Lancet 367:1262–1270CrossRefPubMed
19.
Zurück zum Zitat Herholz K, Carter SF, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 80:S160–S167CrossRefPubMed Herholz K, Carter SF, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 80:S160–S167CrossRefPubMed
20.
Zurück zum Zitat Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S (1996) “Sniffin sticks”: screening of olfactory performance. Rhinology 34:222–226PubMed Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S (1996) “Sniffin sticks”: screening of olfactory performance. Rhinology 34:222–226PubMed
21.
Zurück zum Zitat Koss E, Friedland RP, Ober BA, Jagust WJ (1985) Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. Am J Psychiatry 142:638–640PubMed Koss E, Friedland RP, Ober BA, Jagust WJ (1985) Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. Am J Psychiatry 142:638–640PubMed
22.
Zurück zum Zitat Koss E, Weiffenbach JM, Haxby JV, Friedland RP (1988) Olfactory detection and identification performance are dissociated in early Alzheimer’s disease. Neurology 38:1228–1232PubMed Koss E, Weiffenbach JM, Haxby JV, Friedland RP (1988) Olfactory detection and identification performance are dissociated in early Alzheimer’s disease. Neurology 38:1228–1232PubMed
23.
Zurück zum Zitat Landis BN, Welge-Luessen A, Brämerson A, Bende M, Mueller CA, Nordin S, Hummel T (2009) “Taste strips”––a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers. J Neurol 256:242–248CrossRefPubMed Landis BN, Welge-Luessen A, Brämerson A, Bende M, Mueller CA, Nordin S, Hummel T (2009) “Taste strips”––a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers. J Neurol 256:242–248CrossRefPubMed
24.
Zurück zum Zitat Lang CJ, Leuschner T, Ulrich K, Stössel C, Heckmann JG, Hummel T (2006) Taste in dementing diseases and parkinsonism. J Neurol Sci 248:177–184CrossRefPubMed Lang CJ, Leuschner T, Ulrich K, Stössel C, Heckmann JG, Hummel T (2006) Taste in dementing diseases and parkinsonism. J Neurol Sci 248:177–184CrossRefPubMed
25.
Zurück zum Zitat McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMed
26.
Zurück zum Zitat Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s disease. Arch Neurol 55:84–90CrossRefPubMed Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s disease. Arch Neurol 55:84–90CrossRefPubMed
27.
Zurück zum Zitat Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease. J Nucl Med 47:1778–1786PubMed Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease. J Nucl Med 47:1778–1786PubMed
28.
Zurück zum Zitat Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T, Kobal G (2003) Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 41:2–6PubMed Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T, Kobal G (2003) Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 41:2–6PubMed
29.
Zurück zum Zitat Nestor PJ, Fryer TD, Smielewski P, Hodges JR (2003) Limbic hypometabolism in Alzheimer’s disease and mild cognitive impairment. Ann Neurol 54:343–351CrossRefPubMed Nestor PJ, Fryer TD, Smielewski P, Hodges JR (2003) Limbic hypometabolism in Alzheimer’s disease and mild cognitive impairment. Ann Neurol 54:343–351CrossRefPubMed
30.
Zurück zum Zitat Peters JM, Hummel T, Kratzsch T, Lotsch J, Skarke C, Frolich L (2003) Olfactory function in mild cognitive impairment and Alzheimer’s disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 160:1995–2002CrossRefPubMed Peters JM, Hummel T, Kratzsch T, Lotsch J, Skarke C, Frolich L (2003) Olfactory function in mild cognitive impairment and Alzheimer’s disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 160:1995–2002CrossRefPubMed
31.
Zurück zum Zitat Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985–1992CrossRefPubMed Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985–1992CrossRefPubMed
32.
Zurück zum Zitat Petersen RC, Smith GE, Ivnik RJ, Tangales EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995) Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. J Am Med Assoc 273:1274–1278CrossRef Petersen RC, Smith GE, Ivnik RJ, Tangales EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995) Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. J Am Med Assoc 273:1274–1278CrossRef
33.
Zurück zum Zitat Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308CrossRefPubMed Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308CrossRefPubMed
34.
Zurück zum Zitat Schiffman SS, Clark CM, Warwick ZS (1990) Gustatory and olfactory dysfunction in dementia: not specific to Alzheimer’s disease. Neurobiol Aging 11:597–600CrossRefPubMed Schiffman SS, Clark CM, Warwick ZS (1990) Gustatory and olfactory dysfunction in dementia: not specific to Alzheimer’s disease. Neurobiol Aging 11:597–600CrossRefPubMed
35.
Zurück zum Zitat Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bohmer K (2002) Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer’s disease. Neurobiol Aging 23:397–404CrossRefPubMed Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bohmer K (2002) Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer’s disease. Neurobiol Aging 23:397–404CrossRefPubMed
36.
Zurück zum Zitat Serby M, Larson P, Kalkstein D (1991) The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry 148:357–360PubMed Serby M, Larson P, Kalkstein D (1991) The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry 148:357–360PubMed
37.
Zurück zum Zitat Sewards TV (2004) Dual separate pathways for sensory and hedonic aspects of taste. Brain Res Bull 62:271–283CrossRefPubMed Sewards TV (2004) Dual separate pathways for sensory and hedonic aspects of taste. Brain Res Bull 62:271–283CrossRefPubMed
38.
Zurück zum Zitat Small DM, Gregory MD, Mak YE, Gitelman DR, Mesulam MM, Parrish TB (2003) Dissociation of neural representation of intensity and affective valuation in human gustation. Neuron 39:701–711CrossRefPubMed Small DM, Gregory MD, Mak YE, Gitelman DR, Mesulam MM, Parrish TB (2003) Dissociation of neural representation of intensity and affective valuation in human gustation. Neuron 39:701–711CrossRefPubMed
39.
Zurück zum Zitat Trojanowski JQ, Clark CM, Arai H, Lee VMY (1996) Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer’s disease. Alzheimers Dis Rev 1:77–83 Trojanowski JQ, Clark CM, Arai H, Lee VMY (1996) Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer’s disease. Alzheimers Dis Rev 1:77–83
40.
Zurück zum Zitat Waldton S (1974) Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand 50:539–547CrossRefPubMed Waldton S (1974) Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand 50:539–547CrossRefPubMed
41.
Zurück zum Zitat Wang QS, Tian L, Huang YL, Qin S, He LQ, Zhou JN (2002) Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment. Brain Res 951:77–81CrossRefPubMed Wang QS, Tian L, Huang YL, Qin S, He LQ, Zhou JN (2002) Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment. Brain Res 951:77–81CrossRefPubMed
Metadaten
Titel
Taste in mild cognitive impairment and Alzheimer’s disease
verfasst von
Silke Steinbach
Walter Hundt
Andreas Vaitl
Petra Heinrich
Stefan Förster
Katharina Bürger
Thomas Zahnert
Publikationsdatum
01.02.2010
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 2/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5300-6

Weitere Artikel der Ausgabe 2/2010

Journal of Neurology 2/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.